106612-94-6 | Glucagon-like peptide 1 (Rana catesbeiana), 3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$200.00	$140.00
5mg	95%	in stock	$400.00	$280.00
10mg	95%	in stock	$600.00	$420.00
25mg	95%	in stock	$1,172.00	$820.00

Description

• Catalog Number: AX63202
• Chemical Name: Glucagon-like peptide 1 (Rana catesbeiana), 3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-
• CAS Number: 106612-94-6
• Molecular Formula: C151H228N40O47
• Molecular Weight: 3355.6658
• MDL Number: MFCD00167940
• SMILES: NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCCN)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C

Upstream Synthesis Route

GLP-1(7-37) is a peptide hormone that has shown promising applications in chemical synthesis. This biologically active peptide plays a crucial role in regulating glucose metabolism and insulin secretion in the body. In chemical synthesis, GLP-1(7-37) can be utilized as a key building block for producing peptide derivatives with potential therapeutic benefits. By harnessing the unique properties of GLP-1(7-37), chemists can efficiently design and create novel peptide-based molecules for various applications in drug discovery and development. Additionally, the incorporation of GLP-1(7-37) into chemical synthesis strategies can lead to the development of new pharmaceutical compounds with enhanced biological activity and improved pharmacokinetic profiles.